Related by context. All words. (Click for frequent words.) 69 underwent resection 68 cytoreduction 67 biliary tract cancer 67 radical nephrectomy 67 pancreatic adenocarcinoma 67 ALND 66 transplantation HCT 66 pulmonary metastases 65 NMIBC 65 liver resection 65 underwent surgical resection 65 Surgical resection 65 resectable 65 adenomatous 65 pT2 65 unresectable tumors 65 infrapopliteal 65 bronchogenic carcinoma 64 Mitomycin C 64 locoregional recurrence 64 lymphoid malignancies 64 intestinal metaplasia 64 malignant neoplasm 64 metastatic bladder 64 debulking surgery 64 colorectal carcinoma 64 hepatic metastases 64 pulmonary artery banding 64 total thyroidectomy 64 metastatic gastric 64 underwent radical cystectomy 64 metastatic malignant 63 bifurcated lesions 63 node dissection 63 stage IIIA 63 nonmetastatic 63 concurrent chemoradiation 63 oblimersen 63 metastatic GIST 63 allogeneic hematopoietic stem cell 63 metastatic neuroendocrine tumors 63 pretransplant 63 histologic subtype 63 radiotherapy RT 63 TAXUS Express Stent 63 colorectal liver metastases 63 thymectomy 63 histologically confirmed 63 percutaneous interventions 62 urothelial carcinoma 62 esophageal gastric 62 recurrent metastatic 62 nephron sparing surgery 62 pT3 62 Catheter ablation 62 nondiabetic patients 62 appendiceal 62 T1a 62 graft occlusion 62 lymphadenectomy 62 prostate adenocarcinoma 62 GISTs 62 fallopian tube carcinoma 62 hepatic resection 62 prostate TURP 62 varices 62 chemoradiation therapy 62 everolimus eluting stents 62 metastatic pancreatic 62 metachronous 62 stage IIIb IV 62 nodal metastasis 62 reintervention 62 radical prostatectomy RP 62 pCR 62 skeletal metastases 62 castrate resistant 62 anterior lumbar interbody fusion 62 balloon valvuloplasty 62 tumors GIST 61 chemoembolization 61 locoregional 61 preoperative chemotherapy 61 transarterial 61 conformal radiotherapy 61 renal tumors 61 nephrectomy 61 cervical lymph node 61 percutaneous transluminal coronary angioplasty 61 squamous cell carcinoma SCC 61 VATS lobectomy 61 adjuvant cisplatin 61 gastroesophageal junction 61 prostate carcinoma 61 Cystectomy 61 pamidronate 61 autologous SCT 61 advanced pancreatic neuroendocrine 61 invasive ductal 61 hepatorenal syndrome 61 nephrectomies 61 para aortic 61 recurrent glioblastoma multiforme 61 retransplantation 61 chemoradiotherapy 61 endobronchial 61 recurrent NSCLC 61 pneumonectomy 61 cystectomy 61 spinal metastases 61 radioiodine therapy 61 endoscopic resection 61 postoperative morbidity 61 benign neoplasms 61 revascularized 61 patients undergoing CABG 61 tumor resection 61 metastatic malignant melanoma 61 neoadjuvant therapy 61 peritoneal cancer 61 occlusive disease 61 perioperative mortality 61 peritoneal carcinomatosis 61 mutated K ras 61 resection cavity 61 metaplasia 61 chemoresistant 61 crossclamp 61 cytoreductive surgery 61 biochemical recurrence 61 bladder carcinoma 61 neoadjuvant setting 60 locoregional disease 60 papillary renal cell carcinoma 60 radiochemotherapy 60 saphenous vein grafts 60 deep venous thromboses 60 Coronary artery bypass graft 60 subependymal giant cell 60 allogeneic bone marrow 60 Papillary 60 clinically localized prostate 60 extracranial 60 pancreatic ductal 60 scleral buckling 60 external beam radiotherapy 60 care regimens CCR 60 saphenous vein graft 60 obstructive lesions 60 Vitrectomy 60 stage IIIB 60 segmentectomy 60 gastric adenocarcinoma 60 CYPHER Stent 60 metastatic lesions 60 thrombocytopenic 60 intracranial hemorrhage ICH 60 mediastinal 60 cervical lymph nodes 60 biochemical relapse 60 metastatic renal 60 renal artery stenting 60 Camptosar ® 60 advanced adenomas 60 cutaneous melanoma 60 leukemia AML 60 leiomyomas 60 localized renal 60 Radical prostatectomy 60 clinically detectable 60 non splenectomized 60 functional mitral regurgitation 60 antithymocyte globulin 60 neoplastic lesions 60 ductal carcinomas 60 tumor nodules 60 AV fistula 60 extracapsular extension 60 progression TTP 60 colorectal adenoma 60 adrenalectomy 60 intravesical therapy 60 comparator arm 60 endocrine therapies 60 follicular thyroid cancer 60 achieved CCyR 60 neoadjuvant 60 malignant pleural mesothelioma MPM 60 5-fluorouracil/leucovorin 60 tuberous sclerosis TS 60 carcinoids 60 cranial irradiation 60 distant metastases 60 ischemic mitral regurgitation 60 unresectable liver cancer 60 anastomotic leaks 60 urothelial bladder cancer 60 laparoscopic nephrectomy 60 idiopathic myelofibrosis 60 intracranial tumors 60 resections 60 basal cell carcinoma BCC 60 aortic root replacement 60 carcinoid tumors 60 tenecteplase 60 arteriovenous fistula 59 SSc 59 ascending aortic 59 pericardial effusion 59 mRCC 59 breast pancreatic 59 thoracoscopic lobectomy 59 adjuvant radiotherapy 59 EBRT 59 GORE TAG Device 59 pelvic lymphadenectomy 59 enterococcal 59 cancer mCRC 59 CLL SLL 59 arterial grafts 59 interstitial brachytherapy 59 Legg Calvé Perthes disease 59 CCyR 59 Fontan procedure 59 anti angiogenic agents 59 recurrent GBM 59 prostate carcinomas 59 pulmonary resection 59 anaplastic astrocytomas 59 laparoscopic radical nephrectomy 59 advanced adenoma 59 mediastinitis 59 leiomyoma 59 Thrombin 59 operable breast cancer 59 R0 resection 59 thoracic aortic aneurysms 59 renal pelvis 59 IV NSCLC 59 XYOTAX TM 59 AV fistulas 59 octreotide LAR 59 haematopoietic stem cell 59 lumbar disc herniation 59 resectable pancreatic cancer 59 nodal dissection 59 paroxysmal AF 59 MACCE 59 % CI #.#-#.# [003] 59 primary patency 59 nodal metastases 59 LHRH receptor positive 59 thyroid carcinoma 59 malignant pleural mesothelioma 59 seminal vesicle invasion 59 urothelial cancer 59 Nonsurgical 59 contralateral breast 59 intracavitary 59 neointimal 59 tumor infiltrating lymphocytes 59 neuroendocrine cancers 59 % CI #.#-#.# [007] 59 epithelial ovarian 59 lymph node dissection 59 immunodeficiency disorders 59 axillary dissection 59 unresectable stage 59 stent binary restenosis 59 reoperation 59 lung resection 59 situ CIS 59 transfemoral 59 Lenalidomide 59 Median PFS 59 metastatic adenocarcinoma 59 unresectable locally advanced 59 liver metastases 59 wedge resection 59 cervical spine fusion 59 myeloid metaplasia 59 abdominal irradiation 59 endoscopic ultrasonography 59 intraoperative complications 59 Free Survival PFS 59 pain palliation 59 complete cytogenetic response 59 recurrent glioblastoma multiforme GBM 59 transplantation HSCT 59 transapical 59 haematologic malignancies 59 gastroduodenal 59 radical retropubic prostatectomy 59 mCRPC 59 osteosarcoma Ewing sarcoma 59 sirolimus stent 58 femoral neck fracture 58 HSCT 58 stereotactic radiotherapy 58 urothelial 58 lung metastasis 58 de novo lesions 58 revascularization procedures 58 oral clodronate 58 intraductal 58 retroperitoneal 58 risk reducing salpingo 58 bypass graft CABG surgery 58 distant metastasis 58 TRUS biopsy 58 intra arterial 58 CTEPH 58 ischemia driven 58 autologous transplants 58 BPS IC 58 NSCL cancer 58 median PFS 58 lobectomy 58 pancreatic carcinoma 58 ErbB2 positive 58 oral Hycamtin 58 PSA nadir 58 haematologic 58 Selective Internal 58 parathyroidectomy 58 chemotherapeutic regimens 58 acute myeloid 58 symptomatic intracranial hemorrhage 58 surgical debulking 58 lung metastases 58 graft dysfunction 58 Medullary thyroid cancer 58 Neo Bladder Augment 58 gefitinib Iressa 58 metastatic RCC 58 femoral popliteal 58 Pegylated Liposomal Doxorubicin 58 orthotopic 58 Neoplasms 58 renal cell carcinomas 58 nicardipine 58 surgically resectable 58 lymph node metastasis 58 ANCA associated 58 breast carcinoma 58 esophageal resection 58 dacarbazine DTIC 58 ipsilateral stroke 58 gadolinium enhanced 58 intrahepatic 58 oncologic outcomes 58 ximelagatran 58 microbiologically evaluable 58 cytogenic 58 variceal 58 surgically resected 58 achieved ACR# 58 CR nPR 58 axillary lymph node dissection 58 Proxinium TM 58 OPCAB 58 Operative mortality 58 binary restenosis 58 Coronary artery bypass 58 neoplastic cells 58 postoperative chemotherapy 58 invasive candidiasis 58 p# biomarker 58 esophageal carcinoma 58 KRAS oncogene 58 allogeneic stem cell 58 nadroparin 58 Flu Cy 58 variceal hemorrhage 58 grade squamous intraepithelial 58 sarcomatoid 58 Fully Covered Stent 58 histological subtype 58 CMV reactivation 58 micrometastases 58 hepatectomy 58 Carotid endarterectomy 58 pegylated liposomal doxorubicin 58 gastric carcinoma 58 liver metastasis 58 5FU 58 pituitary adenomas 58 Intra arterial 58 Target Lesion Revascularization TLR 58 FluCAM arm 58 bladder ovarian 58 CsA 58 deferoxamine 58 splenectomized 58 CRp 58 carcinoma HCC 58 percutaneous drainage 58 endothelial keratoplasty 58 HNSCC 58 cardiac allograft vasculopathy 58 Chronic lymphocytic leukemia 58 T1c 58 pancreatic NET 58 hemodialysis patients 58 Kit CD# positive 58 Platinol ® 58 pancreatic resection 58 resected pancreatic cancer 58 tamoxifen Nolvadex ® 58 locoregional control 58 Circulating tumor cells 58 FOLFOX4 58 aneurysmal 58 recurrent glioblastoma 58 Actinic Keratosis 58 fluoropyrimidine 58 ipsilateral breast 58 prospective multicenter study 58 steroid refractory 58 fulminant hepatic failure 58 lung adenocarcinomas 58 IOP lowering 58 DCVax ® Brain 58 thoracic aortic 58 astrocytomas 58 smoldering myeloma 58 euthyroid 58 efficacy evaluable 58 Anaplastic 58 oncological outcomes 58 Motexafin Gadolinium 58 submandibular gland 58 nasopharyngeal carcinoma 58 cytogenetic abnormalities 58 ovarian carcinoma 58 Liver transplantation 58 esophagogastric 57 axillary node dissection 57 mutated KRAS 57 metastatic CRC 57 paclitaxel carboplatin 57 salpingo oophorectomy 57 hepatic metastasis 57 Leydig cell 57 lung esophageal 57 adjuvant tamoxifen 57 Median survival 57 dalteparin 57 extrapleural pneumonectomy 57 endoleak 57 posterolateral fusion 57 Stage IIB 57 hepatocellular carcinomas 57 Percutaneous Transluminal Coronary Angioplasty 57 androgen deprivation 57 femoral neck fractures 57 docetaxel Taxotere ® 57 vWD 57 arterio venous 57 primary hyperparathyroidism 57 symptomatic paroxysmal AF 57 hepatocellular carcinoma HCC 57 Allogeneic 57 dasatinib Sprycel 57 neovascularisation 57 penetrating keratoplasty 57 node metastasis 57 coronary revascularization 57 stage IIIB IV 57 hypervascular tumors 57 tumor xenograft models 57 Platinol ® cisplatin 57 situ LCIS 57 baseline LDH 57 malignant ascites 57 CMV disease 57 Stomatitis 57 luminal diameter 57 transitional cell carcinoma 57 angiographic restenosis 57 chronic GVHD 57 residual stenosis 57 papillary carcinoma 57 sacrocolpopexy 57 digital subtraction angiography 57 leiomyosarcoma 57 eluting stent 57 Median progression 57 Lymphocytic 57 incomplete revascularization 57 ADPKD 57 reimplantation 57 Vidaza azacitidine 57 superficial femoral 57 Leucovorin 57 pegfilgrastim 57 MitraClip device 57 paraganglioma 57 candidemia 57 PAOD 57 Squamous 57 Dacogen decitabine 57 neoadjuvant chemotherapy 57 immunocompetent 57 biliary cancer 57 UPPP 57 metastatic bone 57 colorectal cancer liver metastases 57 cell carcinomas 57 nadolol 57 transthoracic 57 osteochondromas 57 gemcitabine carboplatin 57 bronchoalveolar lavage 57 recanalization 57 colon carcinoma 57 HBeAg negative 57 perioperative morbidity 57 keratoplasty 57 GORE VIABAHN Endoprosthesis 57 mitomycin C 57 fibrin deposition 57 angioplasty stenting 57 ductal adenocarcinoma 57 laparoscopic partial nephrectomy 57 advanced hepatocellular carcinoma 57 HeartMate XVE 57 Sentinel node biopsy 57 Neoadjuvant chemotherapy 57 portal vein thrombosis 57 GW# [003] 57 micrometastasis 57 haematopoietic 57 Adjuvant chemotherapy 57 postoperative radiotherapy 57 completely resected 57 hip resurfacing arthroplasty 57 KRAS wild 57 endometrial carcinoma 57 Endometrial 57 interferon ribavirin 57 hormone receptor negative 57 mesangial 57 Choroidal 57 gemcitabine cisplatin 57 Glioblastoma Multiforme GBM 57 colorectal neoplasms 57 Radiofrequency ablation 57 workhorse lesions 57 symptomatic carotid stenosis 57 BEACOPP 57 Hematopoietic stem cell 57 neurologic progression 57 thymoma 57 biliary tree 57 metastatic renal cell 57 immunosuppressive regimen 57 radical cystectomy 57 refractory metastatic colorectal cancer 57 relapsing remitting MS RRMS 57 small lymphocytic lymphoma 57 carotid artery stenosis 57 severe neutropenia 57 fenestrated 57 internal thoracic artery 57 schwannomas 57 lung bronchus 57 Basal cell 57 tumor necrosis 57 lymph node metastases 57 Arteriovenous 57 undergoing radical cystectomy 57 posttraumatic arthritis 57 nonsmall cell lung cancer 57 ovarian breast 57 Cypher Stent 57 ara C 57 plus gemcitabine 57 peripheral vascular stent 57 prostate cancer CaP 57 Tavocept 57 myeloproliferative disorder 57 Gleevec resistant 57 Stage IIIb 57 postoperative mortality 57 metastatic colorectal 57 submandibular 57 cytogenetic responses 57 taxane chemotherapy 57 alpha1 antitrypsin deficiency 57 malignant neoplasms 57 Ishak fibrosis score 57 revascularisation procedures 57 biliary tract 57 neointimal hyperplasia 57 Coronary Artery Bypass Graft 57 Renal Cell Carcinoma RCC 57 vertebral compression fracture 57 aneurysms AAA 57 precancerous cervical 57 de novo AML 57 MALT lymphoma 57 steatohepatitis 57 #Gy 57 tortuosity 57 estramustine 57 acid phosphatase PAP 57 extranodal 57 bioprosthesis 57 antegrade 57 Accelerated Partial Breast Irradiation 57 daily subcutaneous injections 57 untreated multiple myeloma 57 advanced medullary thyroid 57 osteoid osteoma 57 lung carcinomas 57 peripheral artery 57 elevated LDH 57 artery bypass 57 allogeneic HSCT 57 ePTFE graft 57 curative resection 57 hilar 57 thyroid carcinomas 57 rebleeding 57 cytoreductive nephrectomy 57 Parathyroid Hormone 57 peripheral vasculature 57 enucleation 57 EGFR mutation positive 57 angiographically 57 thetreatment 57 gastric cardia 57 recurrent colorectal cancer 57 cisplatin resistant 57 vinca alkaloids 56 pancreatic islet cell 56 Patients Treated With 56 neoadjuvant treatment 56 pathologic diagnosis 56 colorectum 56 idarubicin 56 Glioblastoma Multiforme 56 gastrointestinal stromal tumor 56 Stage IIIA 56 metastatic liver 56 invasive carcinomas 56 Vascular Wrap 56 moderately emetogenic 56 idiopathic PAH 56 Irinotecan 56 malignant lymphoma 56 EGFR mutant 56 curative therapy 56 multiple myeloma MM 56 Hodgkin lymphoma HL 56 pancreatic lung 56 PSADT 56 operable pancreatic cancer 56 reflux esophagitis 56 chemo resistant 56 recurrent myocardial infarction 56 adenocarcinomas 56 parathyroid 56 pelvic radiotherapy 56 monophasic 56 Thal Dex 56 preoperative PSA 56 obstructive CAD 56 piperacillin tazobactam 56 antiangiogenic drugs 56 descending thoracic 56 hepatobiliary 56 receptor blocker 56 clodronate 56 bone metastasis 56 neurofibromas 56 Hurthle cell 56 ovarian cervical 56 ductal breast cancer 56 fibroma 56 Hepatocellular Carcinoma HCC 56 sternotomy 56 invasive carcinoma 56 Postoperatively 56 infective endocarditis 56 reinfarction 56 mucinous 56 percutaneous intervention 56 benign uterine 56 undetectable HBV DNA 56 total abdominal hysterectomy 56 chronic eosinophilic leukemia 56 metastatic ovarian cancer 56 tiuxetan 56 hyperplastic 56 liposomal doxorubicin 56 pancreatectomy 56 xenograft 56 Doxil ® 56 neoplasias 56 XIENCE V PROMUS Stent 56 huN# DM1 56 medically inoperable 56 colorectal adenocarcinoma 56 DEFLUX 56 gastrointestinal stromal tumors 56 proximal colon 56 untreated metastatic melanoma 56 Transcatheter aortic valve implantation 56 postoperative complication 56 myelodysplastic myeloproliferative diseases 56 tumor progression TTP 56 unfractionated heparin UFH 56 TroVax ® 56 immunomodulatory therapy 56 invasive aspergillosis 56 demonstrated antitumor activity 56 coronary artery bypass grafts 56 malignant fibrous histiocytoma 56 non valvular atrial 56 intermittent hemodialysis 56 PHPT 56 Hormone Refractory Prostate Cancer 56 A1PI 56 Brain metastases 56 carotid artery stent 56 carotid artery stenting CAS 56 ABVD 56 neoplastic 56 complement inhibitor eculizumab 56 Prognostic factors 56 RAS mutations 56 cystic lesions 56 nonalcoholic steatohepatitis NASH 56 paragangliomas 56 NAVISTAR R 56 Prostatic 56 carboplatin paclitaxel 56 fibrinolysis 56 stented 56 myxoid 56 imiquimod cream 56 basal cell skin 56 Vicinium TM 56 histologies 56 Kaplan Meier analysis 56 embolizations 56 cholangiocarcinoma 56 underwent radical prostatectomy 56 SIR Spheres 56 allogeneic hematopoietic cell 56 sleeve lobectomy 56 arteriovenous access 56 genitourinary cancers 56 hepatocellular cancer 56 Radiofrequency Ablation RFA 56 Pemetrexed 56 Diabetic nephropathy 56 chronic thromboembolic pulmonary 56 metastatic renal cell carcinoma 56 multikinase inhibitor 56 coronary stenting 56 resection arthroplasty 56 Wilms tumors 56 anastomotic leak 56 polyposis 56 ß blockers 56 SUVmax 56 HGPIN 56 hematopoietic cell 56 MiCK assay 56 Ebstein anomaly 56 axillary lymph nodes 56 cyclophosphamide methotrexate 56 ocular melanoma 56 Stent thrombosis 56 anaplastic astrocytoma AA 56 essential thrombocythemia ET 56 BrachySil ™ 56 adenoma recurrence 56 pancreatic transplantation 56 transurethral 56 transcatheter closure 56 hydronephrosis 56 RBC transfusion 56 papillary RCC 56 needle aspiration 56 ureteral 56 pulmonary dysfunction 56 removed laparoscopically 56 QTcF 56 normal karyotype 56 papillomas 56 haematological cancers 56 median sternotomy 56 metastatic lymph nodes 56 Fludarabine 56 lymphocytosis 56 anticoagulants blood thinners 56 prostate cancer HRPC 56 unstable angina pectoris 56 intramedullary nailing 56 4mg/kg 56 epithelial tumors 56 trans retinoic acid 56 leukocyte count 56 PEG IFN 56 supratentorial 56 idiopathic pulmonary arterial hypertension 56 hemodynamically significant 56 EBUS 56 isoenzyme 56 Surgical excision 56 IFN beta 56 acute cholecystitis 56 Relapsed Refractory 56 seminoma 56 Halaven 56 restenosis reblockage 56 aneurysm rupture 56 opacification 56 beta 1a 56 mediastinal lymph nodes 56 gastrointestinal stromal tumors GIST 56 HBeAg seroconversion 56 CMV seropositive 56 Autologous stem cell 56 restenotic lesions 56 thyroid nodules 56 diameter stenosis 56 lobular 56 Orally administered 55 BrachySil TM 55 postoperative infection 55 commercialize deforolimus 55 KTP laser 55 transthyretin amyloidosis 55 radioembolization 55 acute thrombosis 55 nonoperative treatment 55 artery stenosis 55 undergone radical prostatectomy 55 femoral shaft fracture 55 Resection 55 Mitral valve repair 55 vinca alkaloid 55 fibrosarcoma 55 HIPEC 55 neuroblastoma tumors 55 tumor excision 55 TNM staging 55 nonischemic 55 liver transplant recipients 55 balloon dilation 55 thrombocytosis 55 peripheral arterial 55 polypoid 55 epirubicin cyclophosphamide 55 malignant pancreatic 55 adjuvant therapies 55 recurrent epithelial ovarian 55 arteriovenous malformations 55 refractory AML 55 aromatase inhibitor therapy 55 resistant hormone refractory 55 bowel resection 55 histologically 55 non squamous 55 pleural effusions 55 urography 55 Breast conserving 55 metastatic basal cell 55 Uricase PEG 55 colectomy 55 administered intraperitoneally 55 symptomatic benign prostatic 55 meniscectomy 55 pancreatic neuroendocrine tumors 55 microsatellite instability 55 gastrointestinal stromal tumors GISTs 55 neoplasm 55 null responder 55 recurrent malignant glioma 55 lymphocytic leukemia 55 Cimzia TM 55 hypervascular 55 neoplasia CIN 55 bladder tumors 55 Vascugel ® 55 Adenomas 55 Peripheral Arterial 55 HER2 positive tumors 55 surgical aortic valve 55 anagrelide 55 stenoses 55 tumor recurrence 55 treat brain aneurysms 55 papillary thyroid carcinoma 55 histologically proven 55 CYT# potent vascular disrupting 55 PEGylated Fab fragment 55 gastric cancers 55 ischemic lesions 55 papillary 55 resected tumors 55 prostate cancer CRPC 55 perioperative complications 55 precursor lesions 55 colorectal lung 55 arthritis PsA 55 Barrett esophagus BE 55 pleomorphic 55 abdominal aortic 55 ORIF 55 lymph node involvement 55 Temsirolimus 55 IIIb 55 Phacoemulsification 55 chemo radiotherapy 55 T2 lesions 55 benign noncancerous 55 pyelonephritis 55 Patients Receiving 55 vein grafts 55 beta estradiol 55 Embozene TM Microspheres 55 tumor histology 55 adriamycin 55 refractory colorectal cancer 55 relapsed MM 55 paclitaxel eluting 55 Sezary syndrome 55 pilocytic astrocytomas 55 chlorambucil 55 elevated transaminases 55 recurrent acute pancreatitis 55 RARP 55 pancreatic ovarian 55 zotarolimus 55 reoperations 55 thromboembolisms 55 cytologically confirmed 55 incisional hernias 55 bowel resections 55 pancreatic prostate 55 neoplasms 55 hematologic toxicity 55 IV melanoma 55 Familial Adenomatous Polyposis 55 Infusion Reactions Severe 55 artery embolization 55 synthase TS 55 pheochromocytoma 55 recombinant tissue plasminogen 55 clinicopathological features 55 median survivals 55 Renal Artery 55 grade cervical intraepithelial 55 IIIA NSCLC 55 calcineurin inhibitor 55 colorectal carcinomas 55 mL/min/#.# m 2 55 neoadjuvant chemoradiotherapy 55 TRAIL R1 55 cerebral vasospasm 55 Acute myeloid leukemia 55 post thrombotic syndrome 55 P = .# 55 intact parathyroid hormone 55 thrombi 55 intratumoral 55 gemcitabine Gemzar ® 55 metastatic lung cancer 55 hyperphenylalaninemia HPA due 55 squamous histology 55 CIN2 + 55 ductal lobular 55 allogenic stem cell 55 balloon dilatation 55 MDA MB 55 allogeneic transplants 55 anti angiogenic therapy 55 CIN3 55 hamartomas 55 myeloablative 55 thoracolumbar spine 55 mcg QD 55 treat benign prostatic 55 MR Angiography 55 mycophenolate 55 FDG PET imaging 55 methotrexate monotherapy 55 Hypertrophic 55 rFSH 55 ERBB2 55 graft patency 55 bypass grafting 55 atherothrombosis